“ The main challenge for orphan drugs in Spain is access, which has become highly complex in recent years ”
In Conversation
“ The fact that Novo Nordisk in Saudi Arabia has been ranked as the No.1 ‘Best Places to Work’ for the last three years and ranked No.1… ”
“ Plasma-derived therapies are unique life-saving treatments based on a very special and finite raw material, therefore regulations should take this into account ”
Speaking from Ipsen’s US headquarters in Cambridge, Massachusetts off the back of a whirlwind first 16 months as the firm’s Chief Business Officer, Philippe-Lopes Fernandes outlines…
The general manager for Recordati Rare Diseases in MENA, Tony Zbeidy, explains why awareness of rare disorders has vastly improved in the region, which has one…
Ali Yehia, Country Manager for Viatris KSA, speaks about the company’s global operations and its plans for KSA, notably to play an active role in the…
“ Sanofi has been quick in the registration process thanks to its fantastic regulatory affairs department and has been able to launch products for multiple myeloma, different… ”
“ As a country, Saudi Arabia wants to match the well-established regulatory systems of North America, Europe, and Japan, but adding a halal component, which is of… ”
“ mAbxience has a different business model than the majority of big biosimilars producers which have vast sales and marketing capabilities. We have a business-to-business (B2B) model,… ”
“ Today, international companies can see the value and the benefit of collaborating with Saudi businesses due to societal changes and government support ”
“ We are opening a new chapter in medicine. The early 2000s were focused on monoclonal antibodies, 2015 to 2025 is all about immune therapy, but 2025… ”
“ I really care about having operational people on the ground because, in the generics business, if you are not fast, you lose ”
